You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 2, August 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Serological Survey for Australia Antigen and Antibody

Stephen J. Newman, MD; David L. Madden, DVM, PhD; Gary L. Gitnick, MD; John L. Sever, PhD, MD

Am J Dis Child. 1971;122(2):129-133.


Abstract

Of 262 institutionalized patients with mental retardation of various etiologies, 10% were positive for Australia antigen by complement fixation (CF) testing, while 34.1% of 138 patients with Down's syndrome were positive. Serum samples from 27 mentally retarded patients with acute, infectious hepatitis, acquired during an epidemic were negative for antigen. Twenty-one of 34 patients (61.8%) with acute hepatitis and two of nine patients (22.2%) with chronic hepatitis had the antigen. Two of 18 women with hepatitis during pregnancy had antigen, and one of their children had antigen in its cord serum, without clinical hepatitis. None of 27 serum specimens from pregnant women who delivered children with Down's syndrome was positive for antigen. Antibody was found primarily in multiply transfused hemophiliacs. In all, 121 specimens were positive for antigen by CF, and 96 by agar gel diffusion, a 79.3% concordance. The CF test was 32- to 64-fold more sensitive than agar gel in detection of antigen. Screening of pretransfusion blood and the elimination of units containing Australia antigen can be expected to lower the incidence of posttransfusion hepatitis.



Author Affiliations

Bethesda, Md; Los Angeles; Bethesda, Md

From the Section on Infectious Diseases, Perinatal Research Branch, National Institute of Neurological Diseases and Stroke, Bethesda, Md (Drs. Newman, Madden, and Sever); and the Department of Medicine, Center for Health Sciences, University of California, Los Angeles (Dr. Gitnick).


Footnotes

Received for publication Feb 11, 1971; accepted April 22, 1971.

Reprint requests to Building 36, Room 5D04, National Institutes of Health, Bethesda, Md 20014 (Dr. Sever).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.